Product
Sm29 Protein
1 clinical trial
2 indications
Indication
Cutaneous LeishmaniasisIndication
Native American myxoid fibrosarcomaClinical trial
Association of Topical Sm29 in Gold Nanoparticles With Intravenous Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania Braziliensis: A Randomized Controlled Trial.Status: Completed, Estimated PCD: 2022-04-06